RPHM
Reneo Pharmaceuticals, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Gregory J. Flesher
IPO Date
2021-04-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Reneo Pharmaceuticals, Inc.
CEO
Gregory J. Flesher
IPO Date
2021-04-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 29,600 |
| $1.41 |
| 19 Sept 2024 | Leonard Braden Michael | 10 percent owner | P-Purchase | Acquired | 806 | $1.40 |
| 19 Sept 2024 | Leonard Braden Michael | 10 percent owner | P-Purchase | Acquired | 55,300 | $1.36 |
| 16 Sept 2024 | Leonard Braden Michael | 10 percent owner | P-Purchase | Acquired | 172,747 | $1.37 |
| 16 Sept 2024 | Leonard Braden Michael | 10 percent owner | P-Purchase | Acquired | 150,000 | $1.31 |
| 16 Sept 2024 | Leonard Braden Michael | 10 percent owner | P-Purchase | Acquired | 36,176 | $1.40 |
| 14 Aug 2024 | Leonard Braden Michael | 10 percent owner | P-Purchase | Acquired | 100,487 | $1.41 |
| 14 Aug 2024 | Leonard Braden Michael | 10 percent owner | P-Purchase | Acquired | 171,339 | $1.39 |
| 16 May 2024 | Leonard Braden Michael | 10 percent owner | P-Purchase | Acquired | 335,000 | $1.54 |